Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) Shares Gap Down – Time to Sell?

Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX)’s share price gapped down before the market opened on Tuesday . The stock had previously closed at $17.85, but opened at $17.41. Telix Pharmaceuticals Limited American Depositary Shares shares last traded at $17.00, with a volume of 61,506 shares changing hands.

Analysts Set New Price Targets

TLX has been the topic of several recent research reports. UBS Group upped their price target on Telix Pharmaceuticals Limited American Depositary Shares from $21.00 to $22.00 and gave the stock a “buy” rating in a research note on Monday, January 27th. William Blair reiterated an “outperform” rating on shares of Telix Pharmaceuticals Limited American Depositary Shares in a research report on Wednesday.

Telix Pharmaceuticals Limited American Depositary Shares Stock Up 2.4 %

The firm’s 50 day moving average is $17.38.

About Telix Pharmaceuticals Limited American Depositary Shares

Telix Pharmaceuticals Ltd. engages in the development and commercialization of several clinical-stage oncology assets. It operates through the following segments: Commercial, Product Development, and Group and Unallocated. The Commercial segment includes sales of Illuccix and other products subsequent to obtaining regulatory approvals.